{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:22:09Z","timestamp":1793827329713,"version":"4.6.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI141900"],"award-info":[{"award-number":["R01AI141900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vaccine.2025.126783","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:50:37Z","timestamp":1739177437000},"page":"126783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Whole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy"],"prefix":"10.1016","volume":"50","author":[{"given":"Ryan","family":"Scalsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Stabler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Mbambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amed","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Lyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Takala-Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126783_bb0005","series-title":"Malaria Vaccine Technology Roadmap","author":"Malaria Vaccine Funders Group","year":"2013"},{"key":"10.1016\/j.vaccine.2025.126783_bb0010","series-title":"Malaria vaccines: preferred product characteristics and clinical development considerations","author":"WHO","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126783_bb0015","series-title":"World malaria report 2024: addressing inequality in the global malaria response","first-page":"320","author":"WHO","year":"2024"},{"issue":"6666","key":"10.1016\/j.vaccine.2025.126783_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1126\/science.adl1805","article-title":"Second malaria vaccine gets WHO green light","volume":"382","author":"Vogel","year":"2023","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.vaccine.2025.126783_bb0025","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic Diversity and Protective Efficacy of the RTS,S\/AS01 Malaria Vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"issue":"527","key":"10.1016\/j.vaccine.2025.126783_bb0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1080\/01621459.2018.1529594","article-title":"Estimating and testing vaccine sieve effects using machine learning","volume":"114","author":"Benkeser","year":"2019","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126783_bb0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","article-title":"Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria\u2019","volume":"31","author":"Takala","year":"2009","journal-title":"Parasite Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126783_bb0040","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1080\/21645515.2021.1947762","article-title":"Novel malaria vaccines","volume":"17","author":"Laurens","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.126783_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102227","article-title":"Current approaches to malaria vaccines","volume":"70","author":"Duffy","year":"2022","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria vaccines since 2000: progress, priorities, products","volume":"5","author":"Duffy","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"24","key":"10.1016\/j.vaccine.2025.126783_bb0055","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","author":"RTS, S Clinical Trials Partnership","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126783_bb0060","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126783_bb0065","series-title":"Malaria","article-title":"Manson's Tropical Infectious Diseases","author":"Cook","year":"2014"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0070","doi-asserted-by":"crossref","DOI":"10.1088\/1748-3182\/3\/4\/046001","article-title":"Mechanics of a mosquito bite with applications to microneedle design","volume":"3","author":"Ramasubramanian","year":"2008","journal-title":"Bioinspir Biomim"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0075","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/14760584.2023.2245890","article-title":"Sporozoite immunization: innovative translational science to support the fight against malaria","volume":"22","author":"Richie","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0080","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s44321-024-00057-7","article-title":"A replication competent plasmodium falciparum parasite completely attenuated by dual gene deletion","volume":"16","author":"Goswami","year":"2024","journal-title":"EMBO Mol Med"},{"issue":"20","key":"10.1016\/j.vaccine.2025.126783_bb0085","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","article-title":"Safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite","volume":"391","author":"Lamers","year":"2024","journal-title":"N Engl J Med"},{"issue":"52","key":"10.1016\/j.vaccine.2025.126783_bb0090","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1016\/j.vaccine.2015.09.110","article-title":"Designing malaria vaccines to circumvent antigen variability","volume":"33","author":"Ouattara","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126783_bb0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications","volume":"207","author":"Ouattara","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126783_bb0100","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009801","article-title":"Global diversity and balancing selection of 23 leading plasmodium falciparum candidate vaccine antigens","volume":"18","author":"Naung","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12936-022-04081-1","article-title":"Genetic diversity of plasmodium falciparum AMA-1 antigen from the Northeast Indian state of Tripura and comparison with global sequences: implications for vaccine development","volume":"21","author":"Nirmolia","year":"2022","journal-title":"Malar J"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000257","article-title":"Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development","volume":"1","author":"Takala","year":"2009","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126783_bb0120","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2018.01.069","article-title":"RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype","volume":"36","author":"Nielsen","year":"2018","journal-title":"Vaccine"},{"issue":"6906","key":"10.1016\/j.vaccine.2025.126783_bb0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89154","article-title":"Protection against plasmodium falciparum malaria by PfSPZ vaccine","volume":"2","author":"Epstein","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41541-022-00510-z","article-title":"A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection","volume":"7","author":"Mordmuller","year":"2022","journal-title":"npj Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126783_bb0140","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1073\/pnas.1615324114","article-title":"Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection","volume":"114","author":"Lyke","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126783_bb0145","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/infdis\/jiv308","article-title":"Hemoglobin C trait provides protection from clinical falciparum malaria in Malian children","volume":"212","author":"Travassos","year":"2015","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","article-title":"Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data","volume":"13","author":"Bejon","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126783_bb0155","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.007948","article-title":"Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens","volume":"10","author":"Trieu","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0160","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.4049\/jimmunol.1003783","article-title":"Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference","volume":"187","author":"Forbes","year":"2011","journal-title":"J Immunol"},{"issue":"52","key":"10.1016\/j.vaccine.2025.126783_bb0165","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1016\/j.vaccine.2015.09.059","article-title":"Large screen approaches to identify novel malaria vaccine candidates","volume":"33","author":"Davies","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126783_bb0170","first-page":"569","article-title":"High-density peptide arrays for malaria vaccine development","volume":"1403","author":"Loeffler","year":"2016","journal-title":"Vaccine Des"},{"issue":"22","key":"10.1016\/j.vaccine.2025.126783_bb0175","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/pmic.200800194","article-title":"Profiling humoral immune responses to P. falciparum infection with protein microarrays","volume":"8","author":"Doolan","year":"2008","journal-title":"Proteomics"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073515","article-title":"Resemblance-ranking peptide library to screen for binders to antibodies on a Peptidomic scale","volume":"23","author":"Jenne","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126783_bb0185","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1074\/mcp.M113.033308","article-title":"Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays","volume":"13","author":"Forsstrom","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/mcp.RA118.000992","article-title":"High-density peptide arrays help to identify linear immunogenic B-cell epitopes in individuals naturally exposed to malaria infection","volume":"18","author":"Jaenisch","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0195","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/s41598-020-60551-z","article-title":"Microarray analyses reveal strain-specific antibody responses to plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination","volume":"10","author":"Bailey","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.126783_bb0200","first-page":"9","article-title":"Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults","author":"Camponovo","year":"2020","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126783_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa611","article-title":"Epitope-specific antibody responses to a plasmodium falciparum subunit vaccine target in a malaria-endemic population","volume":"223","author":"Friedman-Klabanoff","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0210","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41596-022-00766-8","article-title":"PepSeq: a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries","volume":"18","author":"Henson","year":"2023","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0215","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0220","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41467-023-37378-z","article-title":"Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology","volume":"14","author":"Kelley","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"6055","key":"10.1016\/j.vaccine.2025.126783_bb0230","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126783_bb0235","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.139.6.2020","article-title":"Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro","volume":"139","author":"Schofield","year":"1987","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126783_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233840","article-title":"IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents","volume":"15","author":"Hickey","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126783_bb0245","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"2001"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.126783_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(01)00397-0","article-title":"A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay","volume":"254","author":"Tobery","year":"2001","journal-title":"J Immunol Methods"},{"issue":"14","key":"10.1016\/j.vaccine.2025.126783_bb0255","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148086","article-title":"High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of plasmodium vivax malaria","volume":"6","author":"Ioannidis","year":"2021","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126783_bb0260","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/intimm\/dxn102","article-title":"Mass spectrometric identification of an HLA-A*0201 epitope from plasmodium falciparum MSP-1","volume":"20","author":"Carralot","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2025.126783_bb0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1475-2875-12-100","article-title":"Immunoproteomic analysis of plasmodium falciparum antigens using sera from patients with clinical history of imported malaria","volume":"12","author":"Costa","year":"2013","journal-title":"Malar J"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126783_bb0270","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T cell generation","volume":"4","author":"Seder","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/iji.12565","article-title":"ELISpot assay and prediction of organ transplant rejection","volume":"49","author":"Girmanova","year":"2021","journal-title":"Int J Immunogenet"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126783_bb0280","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1128\/IAI.73.9.5799-5808.2005","article-title":"HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated plasmodium falciparum malaria and healthy controls","volume":"73","author":"Lyke","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126783_bb0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.omtm.2017.08.003","article-title":"Profiling the targets of protective CD8(+) T cell responses to infection","volume":"7","author":"Bruder","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.vaccine.2025.126783_bb0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1475-2875-9-241","article-title":"Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein","volume":"9","author":"Sedegah","year":"2010","journal-title":"Malar J"},{"issue":"W1","key":"10.1016\/j.vaccine.2025.126783_bb0295","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2025.126783_bb0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1475-2875-12-185","article-title":"Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the plasmodium falciparum circumsporozoite protein (CSP)","volume":"12","author":"Sedegah","year":"2013","journal-title":"Malar J"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126783_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106241","article-title":"Sterile immunity to malaria after DNA prime\/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes","volume":"9","author":"Sedegah","year":"2014","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.vaccine.2025.126783_bb0310","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1073\/pnas.232580399","article-title":"A cell-free protein synthesis system for high-throughput proteomics","volume":"99","author":"Sawasaki","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126783_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136109","article-title":"Discovery of novel plasmodium falciparum pre-Erythrocytic antigens for vaccine development","volume":"10","author":"Aguiar","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0320","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.01539-07","article-title":"Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates","volume":"76","author":"Tsuboi","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0325","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.2014.861747","article-title":"Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery","volume":"13","author":"Arumugam","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126783_bb0330","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nmeth.1273","article-title":"Human protein factory for converting the transcriptome into an in vitro-expressed proteome","volume":"5","author":"Goshima","year":"2008","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126783_bb0335","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1128\/IAI.72.3.1594-1602.2004","article-title":"Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome","volume":"72","author":"Haddad","year":"2004","journal-title":"Infect Immun"},{"issue":"10B","key":"10.1016\/j.vaccine.2025.126783_bb0340","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1101\/gr.2416604","article-title":"High-throughput generation of P. Falciparum functional molecules by recombinational cloning","volume":"14","author":"Aguiar","year":"2004","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0345","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1038\/s41598-023-32384-z","article-title":"An ultra-high-throughput screen for the evaluation of peptide HLA-binder interactions","volume":"13","author":"Kramer","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.126783_bb0350","doi-asserted-by":"crossref","first-page":"791006","DOI":"10.3389\/fimmu.2022.791006","article-title":"Gnawing between cells and cells in the immune system: friend or foe? A review of Trogocytosis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0355","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41592-018-0305-7","article-title":"T cell antigen discovery via trogocytosis","volume":"16","author":"Li","year":"2019","journal-title":"Nat Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126783_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051155","article-title":"Shaping of T cell functions by Trogocytosis","volume":"10","author":"Nakayama","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0365","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","article-title":"T-scan: a genome-wide method for the systematic discovery of T cell epitopes","volume":"178","author":"Kula","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126783_bb0370","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jmb.2006.12.028","article-title":"Cross-reactivity studies of an anti-plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation","volume":"366","author":"Igonet","year":"2007","journal-title":"J Mol Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0375","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2020.10.004","article-title":"A snapshot of human leukocyte antigen (HLA) diversity using data from the allele frequency net database","volume":"82","author":"Gonzalez-Galarza","year":"2021","journal-title":"Hum Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0380","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.3390\/cimb46070416","article-title":"Conformational alterations of the cell surface of monomeric and dimeric beta2m-free HLA-I (proto-HLA) may enable novel immune functions in health and disease","volume":"46","author":"Ravindranath","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/cei\/uxae038","article-title":"NK-like CD8 T cell: one potential evolutionary continuum between adaptive memory and innate immunity","volume":"217","author":"Wang","year":"2024","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1333426","article-title":"The use of transgenic parasites in malaria vaccine research","volume":"16","author":"Othman","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.126783_bb0395","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fimmu.2018.00807","article-title":"Humanized mouse models for the study of human malaria parasite biology, pathogenesis, and immunity","volume":"9","author":"Minkah","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0400","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0895-4356(00)00258-4","article-title":"Sieve analysis methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation","volume":"54","author":"Gilbert","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126783_bb0405","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/sim.9302","article-title":"Causal inference methods for vaccine sieve analysis with effect modification","volume":"41","author":"Yang","year":"2022","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0410","first-page":"164","article-title":"Assessing trends in vaccine efficacy by pathogen genetic distance","volume":"161","author":"Benkeser","year":"2020","journal-title":"J Soc Fr Statistique (2009)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0415","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/biostatistics\/kxt018","article-title":"Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics","volume":"15","author":"Dai","year":"2014","journal-title":"Biostatistics"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003973","article-title":"Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial","volume":"11","author":"Edlefsen","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126783_bb0425","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1093\/cid\/ciac699","article-title":"Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of phase II and III trial data","volume":"76","author":"Amin","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126783_bb0430","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308942121","article-title":"Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features","volume":"121","author":"Juraska","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0435","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-024-46536-w","article-title":"Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features","volume":"15","author":"Magaret","year":"2024","journal-title":"Nature Communications"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126783_bb0440","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-022-01877-1","article-title":"Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance","volume":"28","author":"Cao","year":"2022","journal-title":"Nat Med"},{"issue":"35","key":"10.1016\/j.vaccine.2025.126783_bb0445","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1016\/j.vaccine.2020.06.035","article-title":"Epitope-based sieve analysis of plasmodium falciparum sequences from a FMP2.1\/AS02(A) vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants","volume":"38","author":"Ouattara","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126783_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003840","article-title":"Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1","volume":"9","author":"Dutta","year":"2013","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126783_bb0455","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00018-023-04712-z","article-title":"Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines","volume":"80","author":"Drew","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126783_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10061090","article-title":"An in silico analysis of malaria pre-Erythrocytic-stage antigens interpreting worldwide genetic data to suggest vaccine candidate variants and epitopes","volume":"10","author":"Ouattara","year":"2022","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0465","doi-asserted-by":"crossref","first-page":"16215","DOI":"10.1038\/s41598-021-95442-4","article-title":"In silico characterisation of putative plasmodium falciparum vaccine candidates in African malaria populations","volume":"11","author":"Ajibola","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126783_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182674","article-title":"Genetic diversity and antibody responses against plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: implication for vaccine development","volume":"12","author":"Patel","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101783","article-title":"Variation in the circumsporozoite protein of plasmodium falciparum: vaccine development implications","volume":"9","author":"Gandhi","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126783_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241426","article-title":"Balancing selection and high genetic diversity of plasmodium vivax circumsporozoite central region in parasites from Brazilian Amazon and Rio de Janeiro Atlantic Forest","volume":"15","author":"Almeida-de-Oliveira","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0485","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12936-020-03451-x","article-title":"Genetic diversity of circumsporozoite protein in plasmodium knowlesi isolates from Malaysian Borneo and Peninsular Malaysia","volume":"19","author":"Chong","year":"2020","journal-title":"Malar J"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126783_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043430","article-title":"Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine","volume":"7","author":"Zeeshan","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126783_bb0495","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1073\/pnas.96.8.4506","article-title":"High recombination rate in natural populations of plasmodium falciparum","volume":"96","author":"Conway","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5443","key":"10.1016\/j.vaccine.2025.126783_bb0500","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.286.5443.1351","article-title":"A genetic map and recombination parameters of the human malaria parasite plasmodium falciparum","volume":"286","author":"Su","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126783_bb0505","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1101\/gr.203711.115","article-title":"Indels, structural variation, and recombination drive genomic diversity in plasmodium falciparum","volume":"26","author":"Miles","year":"2016","journal-title":"Genome Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0510","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/imm.12780","article-title":"Vaccine candidate discovery for the next generation of malaria vaccines","volume":"152","author":"Tuju","year":"2017","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126783_bb0515","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14760584.2021.1882309","article-title":"Correlates of malaria vaccine efficacy","volume":"20","author":"Stanisic","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.126783_bb0520","doi-asserted-by":"crossref","first-page":"1116299","DOI":"10.3389\/fimmu.2023.1116299","article-title":"Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles","volume":"14","author":"Nakamae","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126783_bb0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-023-00799-4","article-title":"Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine","volume":"9","author":"MacMillen","year":"2024","journal-title":"npj Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126783_bb0530","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41590-019-0416-z","article-title":"Humanized immune system mouse models: progress, challenges and opportunities","volume":"20","author":"Allen","year":"2019","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:29:19Z","timestamp":1741793359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":106,"alternative-id":["S0264410X25000805"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126783","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126783"}}